Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a ...

Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...

The deal with Lilly is a crucial boost for Organovo, which ended last year with just $1.2 million in cash and nearly $350 million in debt. Organovo FXR is a clinical drug program focused on farnesoid ...

Among significant research news last week, US CNS specialist Axsome Therapeutics released new Phase III data on its recently ...

Detailed price information for Indust/Producer Dur Alphadex ETF FT (FXR-A) from The Globe and Mail including charting and ...

President Donald Trump, right, meets with Ukrainian President Volodymyr Zelenskyy in the Oval Office at the White House, ...

Discover creative and practical inventions that are simple yet incredibly useful! Using everyday materials, these DIY builds prove that innovation doesn’t have to be complicated. Whether it’s for home ...

Detailed price information for Indust/Producer Dur Alphadex ETF FT (FXR-A) from The Globe and Mail including charting and trades.

The gift that kept on giving finally stopped giving. Thankfully, that gift had given enough for Brandon Palaniuk to cruise ...

Investorideas ( ), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Organovo Hol ...